These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9234532)

  • 1. DNA vaccination for the induction of immune responses against hepatitis C virus proteins.
    Inchauspé G; Major ME; Nakano I; Vitvitski L; Trépo C
    Vaccine; 1997 Jun; 15(8):853-6. PubMed ID: 9234532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
    Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
    J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
    Encke J; zu Putlitz J; Geissler M; Wands JR
    J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses against hepatitis C virus structural proteins following genetic immunisation.
    Inchauspé G; Major ME; Nakano I; Vivitski L; Maisonnas M; Trépo C
    Dev Biol Stand; 1998; 92():163-8. PubMed ID: 9554271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
    Hu GJ; Wang RY; Han DS; Alter HJ; Shih JW
    Vaccine; 1999 Aug; 17(23-24):3160-70. PubMed ID: 10462252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.
    Fournillier A; Depla E; Karayiannis P; Vidalin O; Maertens G; Trépo C; Inchauspé G
    J Virol; 1999 Sep; 73(9):7497-504. PubMed ID: 10438839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
    Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
    DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
    Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
    Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
    J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV.
    Jin J; Yang JY; Liu J; Kong YY; Wang Y; Li GD
    World J Gastroenterol; 2002 Jun; 8(3):505-10. PubMed ID: 12046080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
    Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
    Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
    Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode.
    Nakano I; Maertens G; Major ME; Vitvitski L; Dubuisson J; Fournillier A; De Martynoff G; Trepo C; Inchauspe G
    J Virol; 1997 Sep; 71(9):7101-9. PubMed ID: 9261444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.
    Ma X; Forns X; Gutierrez R; Mushahwar IK; Wu T; Payette PJ; Bukh J; Purcell RH; Davis HL
    Vaccine; 2002 Sep; 20(27-28):3263-71. PubMed ID: 12213395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response.
    Jiao X; Wang RY; Feng Z; Hu G; Alter HJ; W -K Shih J
    J Viral Hepat; 2004 Jan; 11(1):18-26. PubMed ID: 14738554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs.
    Geissler M; Tokushige K; Wakita T; Zurawski VR; Wands JR
    Vaccine; 1998 May; 16(8):857-67. PubMed ID: 9627944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
    Zhu LX; Liu J; Ye Y; Xie YH; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2004 Sep; 10(17):2488-92. PubMed ID: 15300890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.